Best tools for measuring IOP in KC patients

Article

The Pascal dynamic contour tonometer (DCT) and Reichert ocular response analyser (ORA) are the best tools for measuring corneal-compensated intraocular pressure (IOPcc) in patients with keratoconus (KC), according to study results published in the British Journal of Ophthalmology, December.

The Pascal dynamic contour tonometer (DCT) and Reichert ocular response analyzer (ORA) are the best tools for measuring corneal-compensated intraocular pressure (IOPcc) in patients with keratoconus (KC), according to study results published in the British Journal of Ophthalmology, December.

Susan P. Mollan of Birmingham and Midland Eye Centre, Birmingham, UK and colleagues conducted a prospective study assessing the accuracy of IOP measurement in eyes of normal and KC subjects when measured with a variety of different instruments. Central corneal thickness (CCT), corneal hysteresis (CH) and corneal resistance factor (CRF) were also measured.

The researchers found statistically significant differences between the IOP values when measured with the different instruments. CCT, CH and CRF were significantly lower in the KC group, and overall, eyes with thicker corneas registered higher IOP measurements than thinner corneas. The Goldman applanation tonometer (GAT) gave IOP values that were statistically significantly lower than the value as measured with any other instrument, including DCT, ORA and the TonoPen XL tonometer.

Thus the team concluded that IOPcc values were less likely to be compromised when measured with DCT or ORA, and that CH and CRT had more impact than CCT on IOP measurements.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.